HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC) Trademark
Trademark Overview
On Wednesday, June 29, 2022, a trademark application was filed for HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC) with the United States Patent and Trademark Office. The USPTO has given the HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC) trademark a serial number of 97481520. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, February 12, 2024. This trademark is owned by Hematology/Oncology Pharmacy Association, Inc.. The HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC) trademark is filed in the Advertising, Business and Retail Services category with the following description:
association services, namely, promoting the interests of pharmacy practitioners in the area of hematology/oncology to achieve advances in the optimization of care of individuals taking oral anticancer agents for cancer treatment
General Information
| Serial Number | 97481520 |
| Word Mark | HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC) |
| Filing Date | Wednesday, June 29, 2022 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Monday, February 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 8, 2023 |
Trademark Statements
| Pseudo Mark | HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION ORAL CHEMOTHERAPY COLLABORATIVE (OCC) |
| Goods and Services | association services, namely, promoting the interests of pharmacy practitioners in the area of hematology/oncology to achieve advances in the optimization of care of individuals taking oral anticancer agents for cancer treatment |
| NOT AVAILABLE | "ORAL CHEMOTHERAPY COLLABORATIVE" |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 19, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | Monday, August 9, 2021 |
| First Use In Commerce Date | Monday, August 9, 2021 |
Trademark Owner History
| Party Name | Hematology/Oncology Pharmacy Association, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Milwaukee, WI 53202 |
| Party Name | Hematology/Oncology Pharmacy Association, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Milwaukee, WI 53202 |
Trademark Events
| Event Date | Event Description |
| Monday, April 17, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, July 2, 2022 | NEW APPLICATION ENTERED |
| Tuesday, July 19, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 13, 2023 | ASSIGNED TO EXAMINER |
| Monday, April 17, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, April 17, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 30, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 30, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 5, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 8, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 8, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 3, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, January 22, 2024 | USE AMENDMENT FILED |
| Monday, January 22, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Saturday, February 10, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Saturday, February 10, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, February 12, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, February 13, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, February 16, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
